Life Technologies Partners with German Cancer Research Center (DKFZ) to Create World-Class Genome Sequencing Facility

CARLSBAD, Calif. & HEIDELBERG, Germany--(BUSINESS WIRE)--Life Technologies Corporation (NASDAQ: LIFE) and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.